In the second pathway, DA is first converted to 3-methoxytyramine (3-MT) by COMT, and then sequentially acted upon by MAO and ALDH to eventually produce HVA (20, 21)
WHO stresses that without deliberate policies, access to these therapies could worsen existing health disparities
A provider may review symptoms, labs, sleep, nutrition, training habits, and medical history before deciding whether treatment is appropriate
According to the Mounjaro Summary of Product Characteristics (SmPC), these two treatments do not have a known direct pharmacological interaction, as they work through entirely different mechanisms and are metabolised via separate pathways
These emerging multipathway agonists are increasingly being evaluated as systemic therapies to treat non-weight-management indications
"The Chilling Detail from Mary Richardson Kennedy's Suicide That Made Her Doctor Think "Maybe She Didn't Want to Die" (Exclusive)"